Group One Trading
LVTX

Group One Trading’s LAVA Therapeutics LVTX Stock Holding History

Group One Trading’s Portfolio LVTX Stock Details LVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,500
Closed -$22.6K – 8739
2025
Q3 		$22.6K Buy
14,500
+11,400
+368% +$17K ﹤0.01% 6607
2025
Q2 		$4.09K Hold
3,100
– – ﹤0.01% 7168
2025
Q1 		$3.94K Buy
3,100
+3,000
+3,000% +$3.34K ﹤0.01% 6739
2024
Q4 		$95 Sell
100
-10,700
-99% -$16.8K ﹤0.01% 7103
2024
Q3 		$17.9K Sell
10,800
-100
-0.9% -$183 ﹤0.01% 5284
2024
Q2 		$19.6K Buy
10,900
+10,300
+1,717% +$27.2K ﹤0.01% 5247
2024
Q1 		$2K Buy
+600
New +$1.32K ﹤0.01% 6491

Group One Trading's LVTX Position: Q1 2024 in Review

Group One Trading sold out of LAVA Therapeutics (LVTX) in Q1 2024, closing a stake of 100 shares — an estimated $220 sold.

Group One Trading first reported a position in LVTX in Q2 2023 and held it in 3 quarters. The position peaked at $203 in Q2 2023. 20 funds tracked by Wall St. Rank hold LVTX as of Q1 2024.

  • Group One Trading reported no remaining LAVA Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 100 LAVA Therapeutics shares in Q1 2024, an estimated $220.
  • Group One Trading first reported a position in LAVA Therapeutics in Q2 2023 and held it in 3 quarters.
  • Group One Trading's LAVA Therapeutics position peaked at $203 in Q2 2023.
  • 20 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.